Jiancheng Luo

Predicting Tumor Mutational Burden from Liver Cancer Pathological Images Using Convolutional Neural Network

Rui Yan, Ming Du, Hong Zhang, 2019, 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases

X. Yan, Jiancheng Luo, Jin-liang Wang, 2021, Frontiers in Oncology.

Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China

J. Liu, Jiancheng Luo, Rui Zhang, 2022, Thoracic cancer.

IGFBP1hiWNT3Alo Subtype in Esophageal Cancer Predicts Response and Prolonged Survival with PD-(L)1 Inhibitor

Jiancheng Luo, Meichen Liu, Ke-Neng Chen, 2022, Biology.

Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications

Jiancheng Luo, S. Jiao, Shunchang Jiao, 2014, Scientific Reports.

Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancer

F. Gao, Wei Zhou, Jiancheng Luo, 2022, Thoracic cancer.